2-methoxyestradiol has been researched along with Cancer of Liver in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Guo, H; Hu, W; Jiao, M; Jin, T; Li, Y; Lu, M; Ni, J; Wang, Z; Wu, H; Yang, Y; Yao, Y; Yuan, A; Zhang, H; Zheng, S | 1 |
Mei, J; Tang, X; Tao, H | 1 |
Dong, X; Jiang, X; Li, G; Li, J; Ma, L; Ni, S; Qiao, H; Sun, X; Zhao, D; Zhu, H | 1 |
Chen, GG; Ho, RL; Hu, B; Lai, PB; Lee, CG; Leung, BC; Liu, Y; Lu, G; Ren, J; Su, X; Wang, Y; Yang, S | 1 |
Chi, CW; Ko, PH; Liu, TY; Lui, WY; Uen, YH; Yin, PH | 1 |
Abdel-Naim, AB; El Naga, RN; El-Demerdash, E; El-Merzabani, M; Youssef, SS | 1 |
Blaukat, A; Bu, S; Fu, X; Heldin, NE; Landström, M | 1 |
Bachem, MG; Mukhopadhyay, T; Neuhaus, P; Nussler, AK; Pratschke, J; Rueggeberg, A; Scheunert, S; Schumacher, G; Spinelli, A | 1 |
Adlercreutz, H; Carson, M; Loukovaara, M | 1 |
Chau, GY; Chi, CW; Lin, HL; Liu, TY; Lui, WY | 2 |
11 other study(ies) available for 2-methoxyestradiol and Cancer of Liver
Article | Year |
---|---|
2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop.
Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Neoplasm Transplantation; RNA-Binding Proteins; Signal Transduction; Transcription Factors | 2021 |
The anticancer effects of 2-methoxyestradiol on human huh7 cells in vitro and in vivo.
Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude | 2019 |
2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Topics: 2-Methoxyestradiol; Active Transport, Cell Nucleus; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Hepatocellular; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Drug Synergism; Estradiol; Hep G2 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; RNA Interference; Signal Transduction; Sorafenib; Time Factors; Transfection; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |
Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.
Topics: 2-Methoxyestradiol; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 CYP1A2; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Humans; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Niacinamide; Phenylurea Compounds; Receptors, Estrogen; Sorafenib; Tumor Suppressor Protein p53 | 2016 |
Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
Topics: 2-Methoxyestradiol; Animals; Apoptosis; bcl-X Protein; Carcinoma, Hepatocellular; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Glucocorticoids; Humans; Lactic Acid; Liver Neoplasms; Mice; Proto-Oncogene Proteins c-bcl-2; Stress, Physiological | 2008 |
Cytotoxic effects of 2-methoxyestradiol in the hepatocellular carcinoma cell line HepG2.
Topics: 2-Methoxyestradiol; Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 9; Cell Line, Tumor; Dose-Response Relationship, Drug; Estradiol; Flow Cytometry; G2 Phase; Humans; Liver Neoplasms; Vascular Endothelial Growth Factor A | 2009 |
Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells.
Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Apoptosis; Breast; Breast Neoplasms; Carcinoma; Caspases; Cell Division; Colonic Neoplasms; Endothelium; Estradiol; Female; Humans; Kinetics; Liver Neoplasms; Male; Mitogen-Activated Protein Kinases; Pertussis Toxin; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Mas; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 2002 |
A very low toxic agent induces apoptosis and reduces growth of human hepatocellular carcinoma cells.
Topics: 2-Methoxyestradiol; Apoptosis; Carcinoma, Hepatocellular; Cell Count; Cell Line, Tumor; Cell Proliferation; Estradiol; Hepatocytes; Humans; In Vitro Techniques; Liver Neoplasms | 2006 |
Regulation of sex-hormone-binding globulin production by endogenous estrogens in vitro.
Topics: 2-Methoxyestradiol; Carcinoma, Hepatocellular; Estradiol; Estriol; Estrogens; Estrone; Humans; Hydroxyestrones; Liver Neoplasms; Receptors, Estrogen; RNA, Messenger; Sex Hormone-Binding Globulin; Tumor Cells, Cultured | 1995 |
Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species.
Topics: 2-Methoxyestradiol; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Survival; DNA Fragmentation; Docetaxel; Estradiol; Flow Cytometry; Humans; Liver Neoplasms; Microtubules; Paclitaxel; Reactive Oxygen Species; Taxoids; Tumor Cells, Cultured | 2000 |
Male predominance in hepatocellular carcinoma: new insight and a possible therapeutic alternative.
Topics: 2-Methoxyestradiol; Androgens; Carcinoma, Hepatocellular; Combined Modality Therapy; Estradiol; Female; Humans; Liver; Liver Neoplasms; Male; Models, Biological; Sex Factors | 2000 |